244 related articles for article (PubMed ID: 30391930)
1. Regulatory effect of hsa-miR-5590-3P on TGFβ signaling through targeting of TGFβ-R1, TGFβ-R2, SMAD3 and SMAD4 transcripts.
Abedini Bakhshmand E; Soltani BM
Biol Chem; 2019 Apr; 400(5):677-685. PubMed ID: 30391930
[TBL] [Abstract][Full Text] [Related]
2. Hsa-miR-5582-3P regulatory effect on TGFβ signaling through targeting of TGFβ-R1, TGFβ-R2, SMAD3, and SMAD4 transcripts.
Abedini Bakhshmand E; Mohammad Soltani B; Fasihi A; Mowla SJ
J Cell Biochem; 2018 Dec; 119(12):9921-9930. PubMed ID: 30129155
[TBL] [Abstract][Full Text] [Related]
3. Hsa-miR-5195-3P induces downregulation of TGFβR1, TGFβR2, SMAD3 and SMAD4 supporting its tumor suppressive activity in HCT116 cells.
Jahangiri Moez M; Bjeije H; Soltani BM
Int J Biochem Cell Biol; 2019 Apr; 109():1-7. PubMed ID: 30659889
[TBL] [Abstract][Full Text] [Related]
4. Introduction of miR-3613-3p as a regulator of transforming growth factor-β (TGF-β) signaling pathway in colorectal cancer.
Jafarian M; Hasannia T; Badameh P; Behmanesh M; Soltani BM
Mol Biol Rep; 2024 Jun; 51(1):728. PubMed ID: 38861185
[TBL] [Abstract][Full Text] [Related]
5. Downregulated miR-495-3p in colorectal cancer targets TGFβR1, TGFβR2, SMAD4 and BUB1 genes and induces cell cycle arrest.
Kabiri F; Medlej A; Saleh AJ; Aghdami N; Khani M; Soltani BM
Cancer Treat Res Commun; 2023; 35():100702. PubMed ID: 37044020
[TBL] [Abstract][Full Text] [Related]
6. Experimental evidences for hsa-miR-497-5p as a negative regulator of SMAD3 gene expression.
Jafarzadeh M; Soltani BM; Dokanehiifard S; Kay M; Aghdami N; Hosseinkhani S
Gene; 2016 Jul; 586(2):216-21. PubMed ID: 27063509
[TBL] [Abstract][Full Text] [Related]
7. Hsa-miR-587 Regulates TGFβ/SMAD Signaling and Promotes Cell Cycle Progression.
Jahangirimoez M; Medlej A; Tavallaie M; Mohammad Soltani B
Cell J; 2020 Jul; 22(2):158-164. PubMed ID: 31721529
[TBL] [Abstract][Full Text] [Related]
8. LOC646329 long non-coding RNA sponges miR-29b-1 and regulates TGFβ signaling in colorectal cancer.
Javanmard AR; Dokanehiifard S; Bohlooli M; Soltani BM
J Cancer Res Clin Oncol; 2020 May; 146(5):1205-1215. PubMed ID: 32034483
[TBL] [Abstract][Full Text] [Related]
9. Cell specific tumor suppressor effect of Hsa-miR-1226-3p through downregulation of HER2, PIK3R2, and AKT1 genes.
Mohamadzade Z; M Soltani B; Ghaemi Z; Hoseinpour P
Int J Biochem Cell Biol; 2021 May; 134():105965. PubMed ID: 33675995
[TBL] [Abstract][Full Text] [Related]
10. Hsa-miR-590-5p Interaction with SMAD3 Transcript Supports Its Regulatory Effect on The TGFβ Signaling Pathway.
Jafarzadeh M; Soltani BM
Cell J; 2016; 18(1):7-12. PubMed ID: 27054113
[TBL] [Abstract][Full Text] [Related]
11. Introduction of hsa-miR-512-3p as a new regulator of HER2 signaling pathway in breast cancer.
Mohamadzade Z; Mahjoubi F; Soltani BM
Breast Cancer Res Treat; 2021 Jan; 185(1):95-106. PubMed ID: 32974790
[TBL] [Abstract][Full Text] [Related]
12. Latency-Associated Transcript-Derived MicroRNAs in Herpes Simplex Virus Type 1 Target SMAD3 and SMAD4 in TGF-β/Smad Signaling Pathway.
Shojaei Jeshvaghani Z; Arefian E; Asgharpour S; Soleimani M
Iran Biomed J; 2021 May; 25(3):169-79. PubMed ID: 33546553
[TBL] [Abstract][Full Text] [Related]
13. GATA3 transcription factor abrogates Smad4 transcription factor-mediated fascin overexpression, invadopodium formation, and breast cancer cell invasion.
Sun J; He H; Pillai S; Xiong Y; Challa S; Xu L; Chellappan S; Yang S
J Biol Chem; 2013 Dec; 288(52):36971-82. PubMed ID: 24235142
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA‑331 inhibits isoproterenol‑induced expression of profibrotic genes in cardiac myofibroblasts via the TGFβ/smad3 signaling pathway.
Yousefi F; Soltani BM; Rabbani S
Sci Rep; 2021 Jan; 11(1):2548. PubMed ID: 33510328
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-499-5p inhibits transforming growth factor-β1-induced Smad2 signaling pathway and suppresses fibroblast proliferation and collagen synthesis in rat by targeting TGFβ-R1.
Zhao Q; Yang W; Li X; Yuan H; Guo J; Wang Y; Shan Z
Mol Biol Rep; 2023 Dec; 50(12):9757-9767. PubMed ID: 37676431
[TBL] [Abstract][Full Text] [Related]
16. Negative control of TRAIL-R1 signaling by transforming growth factor β1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1.
Radke DI; Ungefroren H; Helm O; Voigt S; Alp G; Braun H; Hübner S; Dilchert J; Sebens S; Adam D; Kalthoff H; Trauzold A
Cell Signal; 2016 Nov; 28(11):1652-62. PubMed ID: 27492861
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of microRNA-574-3p in a human gastric cancer cell line AGS by TGF-β1.
Zhang R; Wang M; Sui P; Ding L; Yang Q
Gene; 2017 Mar; 605():63-69. PubMed ID: 28042090
[TBL] [Abstract][Full Text] [Related]
18. Identification of a gadd45beta 3' enhancer that mediates SMAD3- and SMAD4-dependent transcriptional induction by transforming growth factor beta.
Major MB; Jones DA
J Biol Chem; 2004 Feb; 279(7):5278-87. PubMed ID: 14630914
[TBL] [Abstract][Full Text] [Related]
19. Novel mutations in Smad proteins that inhibit signaling by the transforming growth factor beta in mammalian cells.
Prokova V; Mavridou S; Papakosta P; Petratos K; Kardassis D
Biochemistry; 2007 Dec; 46(48):13775-86. PubMed ID: 17994767
[TBL] [Abstract][Full Text] [Related]
20. LncRNA PART-1 targets TGFBR2/Smad3 to regulate cell viability and apoptosis of chondrocytes via acting as miR-590-3p sponge in osteoarthritis.
Lu C; Li Z; Hu S; Cai Y; Peng K
J Cell Mol Med; 2019 Dec; 23(12):8196-8205. PubMed ID: 31571401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
